Dr. Venkat emphasizes individualized care for upper tract urothelial carcinoma cases
“We’re not doing enough lymph node dissections in upper tract disease,” says Siv Venkat, MD, FRCSC.
In this video, Siv Venkat, MD, FRCSC, discusses the takeaways and further research associated with the study, “Comparison of radical nephroureterectomy and segmental ureterectomy in upper tract urothelial carcinoma,” presented recently at the 2021 Society of Urologic Oncology Annual Meeting. Venkat is a urologic oncology fellow at Weill Cornell Medicine and New York-Presbyterian Hospital in New York City, New York.
Advancing bladder cancer care: The importance of integrating mental health support
September 9th 2024"I think the fact that we're having these conversations, that they are being talked about at national meetings, and that we are bringing the patient voice into this is hugely important," says Mary W. Dunn, MSN, NP-C, OCN, RN.
Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
December 7th 2021“It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
